Dr. Alan John Wilson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 S 14th St, Herrin, IL 62948 Phone: 618-942-2171 Fax: 618-351-4917 |
Dr. Eric A Ruebke, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 S 14th St, Herrin, IL 62948 Phone: 618-942-2171 Fax: 618-988-6186 |
Jaswant S Sidhu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 S 14th St, Herrin, IL 62948 Phone: 618-942-2171 Fax: 618-351-4917 |
Dobroslawa Reschke, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 201 S 14th St, Herrin, IL 62948 Phone: 618-942-2171 Fax: 618-351-4917 |
Dr. Joshua James Miksanek, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 S 14th St, Herrin, IL 62948 Phone: 618-942-2171 Fax: 618-988-6186 |
Scott Wesley Cranick, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 S 14th St, Herrin, IL 62948 Phone: 618-942-2171 Fax: 618-351-4917 |
News Archive
Scientists from the Vision Cooperative Research Centre in Australia today announced that myopia, or short-sightedness, can be controlled with new technology. This ground breaking discovery was based on research conducted by Vision CRC partners - the University of Houston College of Optometry and the Brien Holden Vision Institute, located at the University of New South Wales.
New methods that enhance the quality of myocardial perfusion imaging were developed in a recent study completed at the University of Eastern Finland.
One in three people who die in U.S. hospitals have sepsis, the body's extreme response to infection that can lead to multiple organ failure. Diagnosis can take up to five days, but death may take only hours from the initial onset of sepsis.
The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines —produced from healthy and tumour cells from the patient him or herself— and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.
› Verified 5 days ago